Floatz logo

GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM

Lymphoma, B-Cell

Asan Medical Centerprotein_peptidePhase 1/2Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
73/ 100

Competitive context

317 Active assets in the Lymphoma, B-Cell cohort.

Asset / SponsorPhaseRating
VINDESINE
Children's Cancer Group, China
Phase 4BBB
cc-5013
Shanghai Junshi Bioscience Co., Ltd.
Phase 4BBB
Odronextamab
University of Birmingham
Phase 3BBB
Cytosin-Arabinosid
Children's Cancer Group, China
Phase 4BBB
METHOTREXATE
Children's Cancer Group, China
Phase 4BBB

View all 50 →

Same molecule, other indications

GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM is also rated in:

plasma cell myelomaDormant
BB
Indicative ·
69 / 100
View asset →
neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
DLBCLDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →